J&J To Pay $117M, Resolving Mesh Marketing Suits In 41 States
Johnson & Johnson and subsidiary Ethicon will pay $117m to settle state lawsuits alleging that their marketing misrepresented the safety and risks of transvaginal mesh devices.
You may also be interested in...
Recall announcement doesn't mention litigation J&JU faces in multiple states alleging use of Johnson's Baby Powder causes cancer due from talc in formulation. But firm's sensitivity to consumer complaints or adverse event reports linked to brand is clear with talc-related litigation as backdrop.
An $800m lawsuit filed by the state of California against Johnson & Johnson for alleged fraudulent marketing of pelvic mesh products is in the hands of a state judge after the conclusion of a 10-week trial. This is the first lawsuit brought by a state against a pelvic mesh manufacturer to go to trial.
The US agency is relaxing some regulatory requirements on facial masks and actively pursuing ways to reprocess N95 respirators used by medical staff under an immediately-in-effect guidance document.